FIELD: medicine.
SUBSTANCE: proposed group of inventions relates to the field of medicine, in particular to molecular genetic diagnostics. A method and analytical system for the diagnosis of lung cancer are proposed, including primers and TaqMan probes for sequences of 7 combinations of 10 micro-RNAs: miR-107/miR-222-3p, miR-19b-3p/miR-484, miR-150-5p/miR-144-5p, miR-484/miR-374a-5p, miR-484/miR-324-5p, miR-22-5p/miR-324-5p, miR-374a-5p/miR-133b.
EFFECT: proposed group of inventions provides development of a method for the differential diagnosis of malignant lung tumors with 100% sensitivity, specificity and accuracy.
3 cl, 8 tbl, 30 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHODS FOR PATHOLOGICAL CHANGES DETECTION IN ORGAN OR SYSTEM OF ORGANS | 2012 |
|
RU2626540C2 |
| ONCOLYTIC VIRAL VECTORS AND THEIR APPLICATION | 2018 |
|
RU2771110C2 |
| METHOD FOR MINIMALLY INVASIVE DIAGNOSIS OF GLIOBLASTOMAS | 2022 |
|
RU2788815C1 |
| DRUG FOR TREATMENT OF TISSUE FIBROSIS BASED ON COMPONENTS OF SECRETOME OF MESENCHYMAL STROMAL CELLS, METHOD FOR OBTAINING AND APPLYING REMEDY | 2020 |
|
RU2766707C1 |
| VERSIONS OF RECOMBINANT AAV AND USE THEREOF | 2015 |
|
RU2738421C2 |
| METHOD FOR MINIMALLY INVASIVE DIAGNOSIS OF MENINGIOMAS AND GLIAL TUMORS WITH SPECIFICATION OF THE DEGREE OF MALIGNANCY | 2022 |
|
RU2788814C1 |
| TEST SYSTEM “miR-M-SCREEN” FOR PREDICTING THE DEVELOPMENT OF METASTASES IN PATIENTS WITH COLORECTAL CANCER BASED ON THE LEVEL OF miR-26a AND miR-143 MICRO-RNA IN BLOOD PLASMA | 2022 |
|
RU2786386C1 |
| COMPOSITION COMPRISING AN ENCAPSULATED ANTAGOMIR | 2014 |
|
RU2668794C2 |
| BIOMARKERS OF TRAUMATIC BRAIN INJURY | 2017 |
|
RU2771757C2 |
| ONCOLYTIC VIRAL VECTORS AND USE THEREOF | 2017 |
|
RU2749050C2 |
